Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT), a two-arm, randomized, observer-blind, controlled phase IIb national multicentre clinical trial: study protocol

Saved in:
Bibliographic Details
Title: Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT), a two-arm, randomized, observer-blind, controlled phase IIb national multicentre clinical trial: study protocol
Authors: Driedger, Jan H.1 (AUTHOR), Schröter, Julian1 (AUTHOR), Hertzberg, Christoph (AUTHOR), Weschke, Bernhard (AUTHOR), Kaindl, Angela M. (AUTHOR), Lücke, Thomas (AUTHOR), Thiels, Charlotte (AUTHOR), Klotz, Kerstin Alexandra (AUTHOR), Fazeli, Walid (AUTHOR), Rostásy, Kevin (AUTHOR), Wiethoff-Ubrig, Lucia (AUTHOR), Kaiser, Olaf (AUTHOR), Trollmann, Regina (AUTHOR), Mammadova, Dilbar (AUTHOR), Schubert-Bast, Susanne (AUTHOR), Bach, Alexia (AUTHOR), Eckenweiler, Matthias (AUTHOR), Schönberger, Jan (AUTHOR), Martakis, Kyriakos (AUTHOR), Hahn, Andreas (AUTHOR)
Source: Orphanet Journal of Rare Diseases. 1/6/2025, Vol. 20, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17501172
DOI:10.1186/s13023-024-03495-1